{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:17:20Z","timestamp":1774563440375,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012360","name":"Heart of England NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.nmd.2020.12.009","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T03:57:57Z","timestamp":1610164677000},"page":"212-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Persistently elevated CK and lysosomal storage myopathy associated with mucolipin 1 defects"],"prefix":"10.1016","volume":"31","author":[{"given":"Alberto A.","family":"Zambon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Lemaigre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Sewry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sarkozy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.12.009_bib0001","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/79095","article-title":"Identification of the gene causing mucolipidosis type IV","volume":"26","author":"Bargal","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2020.12.009_bib0002","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(02)03670-0","article-title":"Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway","volume":"532","author":"LaPlante","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nmd.2020.12.009_bib0003","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/hmg\/9.17.2471","article-title":"Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel","volume":"9","author":"Sun","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2020.12.009_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ceca.2014.10.008","article-title":"The role of TRPMLs in endolysosomal trafficking and function","volume":"58","author":"Venkatachalam","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nmd.2020.12.009_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/WNL.59.3.306","article-title":"The neurogenetics of mucolipidosis type IV","volume":"59","author":"Altarescu","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.12.009_bib0006","unstructured":"Schiffmann R, Grishchuk Y, Goldin E. Mucolipidosis IV. Adam M, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132020. 2005 Jan 28 [updated 2015 Jul 30]. PMID: 20301393."},{"key":"10.1016\/j.nmd.2020.12.009_bib0007","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2011.06.006","article-title":"Mucolipidosis type IV: an update","volume":"104","author":"Wakabayashi","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.12.009_bib0008","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/jnc.14462","article-title":"Current concepts in the neuropathogenesis of mucolipidosis type IV","volume":"148","author":"Boudewyn","year":"2019","journal-title":"J Neurochem"},{"key":"10.1016\/j.nmd.2020.12.009_bib0009","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2002-34496","article-title":"Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin","volume":"33","author":"Bargal","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2020.12.009_bib0010","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/hmg\/ddx158","article-title":"Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV","volume":"26","author":"Li","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2020.12.009_bib0011","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm.3611","article-title":"The intracellular Ca(2)(+) channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy","volume":"20","author":"Cheng","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2020.12.009_bib0012","doi-asserted-by":"crossref","first-page":"eaaz2736","DOI":"10.1126\/sciadv.aaz2736","article-title":"Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models","volume":"6","author":"Yu","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.nmd.2020.12.009_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2008-1059563","article-title":"A muscle disorder as presenting symptom in a child with mucolipidosis IV","volume":"14","author":"Zlotogora","year":"1983","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2020.12.009_bib0014","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0387-7604(12)80220-8","article-title":"Muscle involvement in mucolipidosis IV","volume":"12","author":"Weitz","year":"1990","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2020.12.009_bib0015","first-page":"73","article-title":"Morphologic and chemical biopsy findings in mucolipidosis IV","volume":"1","author":"Goebel","year":"1982","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.nmd.2020.12.009_bib0016","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajmg.1320120308","volume":"12","author":"Crandall","year":"1982","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nmd.2020.12.009_bib0017","unstructured":"gnomAD IB. Vol. 6. 1393 [cited 2019 May 14]. p. 103. Available from: https:\/\/gnomad.broadinstitute.org\/."},{"key":"10.1016\/j.nmd.2020.12.009_bib0018","unstructured":"Ellard S.B.E., Owens M., Eccles D.M., Abbs S., Zandra C. ACGS best practice guidelines for variant classification 2019. Available from: https:\/\/www.clinicalgenome.org\/working-groups\/sequence-variant-interpretation\/."},{"key":"10.1016\/j.nmd.2020.12.009_bib0019","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/acn3.662","article-title":"Autophagic vacuolar myopathy is a common feature of CLN3 disease","volume":"5","author":"Radke","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2020.12.009_bib0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nmd.2008.04.010","article-title":"Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle","volume":"18","author":"Malicdan","year":"2008","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.nmd.2020.12.009_bib0021","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00401-019-02059-z","article-title":"MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement","volume":"138","author":"Donkervoort","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2020.12.009_bib0022","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng.2851","article-title":"Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling","volume":"46","author":"Logan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2020.12.009_bib0023","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.celrep.2019.09.063","article-title":"Dysregulation of mitochondrial Ca(2+) uptake and sarcolemma repair underlie muscle weakness and wasting in patients and mice lacking MICU1","volume":"29","author":"Debattisti","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.nmd.2020.12.009_bib0024","first-page":"219","article-title":"Mitochondrial fragmentation enables localized signaling required for cell repair","author":"Horn","year":"2020","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2020.12.009_bib0025","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1007\/s00018-018-2888-7","article-title":"Cellular mechanisms and signals that coordinate plasma membrane repair","volume":"75","author":"Horn","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nmd.2020.12.009_bib0026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ncb0109-7","article-title":"Membrane repair redux: redox of MG53","volume":"11","author":"McNeil","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.nmd.2020.12.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247136","article-title":"ESCRT machinery is required for plasma membrane repair","volume":"343","author":"Jimenez","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.nmd.2020.12.009_bib0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcdb.2015.10.031","article-title":"Calcium signaling in membrane repair","volume":"45","author":"Cheng","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.nmd.2020.12.009_bib0029","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.physiol.010908.163216","article-title":"Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies","volume":"71","author":"Wallace","year":"2009","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.nmd.2020.12.009_bib0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1083\/jcb.201212142","article-title":"The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy","volume":"201","author":"Rahimov","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2020.12.009_bib0031","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/cdd.2016.127","article-title":"Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy","volume":"24","author":"Vila","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.nmd.2020.12.009_bib0032","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(01)00421-4","article-title":"Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes","volume":"106","author":"Reddy","year":"2001","journal-title":"Cell"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620307033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620307033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:08Z","timestamp":1760775008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620307033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0960896620307033"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.12.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistently elevated CK and lysosomal storage myopathy associated with mucolipin 1 defects","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}